Maravai LifeSciences Reports Second Quarter 2025 Financial Results
Maravai LifeSciences Reports Second Quarter 2025 Financial Results GlobeNewswire August 11, 2025 Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings Quarterly base business revenue, which excludes revenue from high-volume CleanCap(R) for commercialized vaccine programs, grew 5% year-over-year Net Loss Reduction, Positive Adjusted EBITDA and Positive Free […]